vip peptide price

Evaluating VIP Peptide Price and Laboratory Acquisition Value

The primary factors determining VIP peptide price across research supply channels include synthesis complexity, analytical purity standards, batch-specific HPLC and mass spectrometry verification, and rigorous endotoxin screening. High-purity Vasoactive Intestinal Peptide synthesized in GMP-compliant facilities commands premium valuation due to the necessity of preventing trace sequence truncations during solid-phase peptide synthesis (SPPS). Obtaining fully validated, high-grade reagents guarantees experimental consistency across sensitive in vitro and ex vivo assays.

When purchasing compounds through the PX1 Research catalog, research teams gain access to verified analytical documentation for every lot. Evaluating the true value of a reagent extends beyond base unit cost; acquiring unverified materials risks introducing analytical artifacts, variable receptor binding kinetics, or cellular toxicity caused by endotoxin contamination or residual TFA (trifluoroacetic acid) salts.

Vasoactive Intestinal Peptide (VIP) Structural Overview and Receptor Affinity

Vasoactive Intestinal Peptide (VIP) is a basic 28-residue peptide derived from a larger precursor protein (prepro-VIP) belonging to the secretin/glucagon superfamily of regulatory peptides. Its primary sequence—H-His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2—is highly conserved across mammalian species, reflecting its essential role in evolutionary neurobiology and cell signaling.

In laboratory models, VIP exerts its biological actions primarily through activation of two class B G-protein-coupled receptors: VPAC1 and VPAC2. Both receptors are coupled to Gαs proteins, which stimulate adenylate cyclase upon agonist binding, resulting in elevated intracellular cyclic adenosine monophosphate (cAMP) and activation of protein kinase A (PKA). Preclinical investigations utilizing the VIP peptide catalog item focus on detailing these downstream intracellular signaling cascades and their regulatory roles in smooth muscle relaxation, cytokine modulation, and epithelial fluid transport.

Preclinical Research Mechanisms: VPAC Signaling Pathways and In Vitro Assays

In vitro models demonstrate that VIP plays a crucial regulatory role in mediating immune cell differentiation and suppressing pro-inflammatory cytokine secretion. In isolated macrophage and microglial cell cultures, VPAC1 activation by VIP inhibits NF-κB nuclear translocation, subsequently reducing the transcription of TNF-α, IL-6, and inducible nitric oxide synthase (iNOS). Researchers exploring cellular immunomodulation frequently consult the PX1 Research database to examine standardized assay protocols for receptor binding studies.

Beyond immune cell modulation, ex vivo arterial and vascular ring tissue preparations demonstrate that VIP induces potent vasodilation independently of endothelial cell integrity in certain microvascular beds, while relying on nitric oxide synthase pathways in others. Understanding these tissue-specific response curves requires high-purity research peptides free from truncated sequence impurities that could otherwise act as competitive antagonists or alter binding affinity values.

Key Technical Metrics That Dictate VIP Peptide Price and Quality

Laboratory purchasers assessing VIP peptide price must systematically evaluate several rigorous quality parameters prior to committing institutional funds. High-tier research peptides undergo rigorous multi-step verification to ensure that sequence integrity and physical purity meet strict academic and biotech benchmarks.

Key criteria defining research-grade VIP peptide quality include:

• Chromatographic Purity (RP-HPLC): Greater than or equal to 98.0% peak area confirmation, ensuring the absence of deletion sequences or oxidation products. • Mass Spectrometry Identity (ESI-MS): Exact molecular weight validation (monoisotopic mass 3325.8 Da) matching theoretical sequence calculations. • Endotoxin Control: Quantitative Chromogenic LAL assay screening verifying levels below <0.01 EU/mg to prevent non-specific immune activation in cell culture. • Residual Solvent & Counterion Content: Standardized lyophilization procedures to minimize residual trifluoroacetic acid (TFA) and heavy metal contaminants. • Domestic Synthesis & Quality Control: Manufactured in GMP-compliant, ISO 17025 accredited facilities within the USA. • Lot Traceability & Logistics: Complete batch history accompanied by a lot-specific Certificate of Analysis (COA) and same-day dispatch from California and Arizona distribution hubs.

Comparative Analysis: VIP vs. PACAP and Secretin Superfamily Peptides

Vasoactive Intestinal Peptide shares significant sequence homology and functional overlap with other members of the glucagon/secretin peptide superfamily. Most notably, Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) shares high structural homology with VIP and binds to both VPAC1 and VPAC2 receptors with comparable affinity, while maintaining exclusive selectivity for the PAC1 receptor.

In comparative receptor binding studies, researchers often evaluate PACAP-38 alongside VIP to differentiate between PAC1-mediated and VPAC1/2-mediated intracellular signaling mechanisms. Similarly, investigations focused on gastrointestinal peptide signaling may compare VIP against BPC-157 or Semaglutide to contrast classical neuropeptide GPCR activation against synthetic repair peptides and metabolic inkretin mimetics. Understanding these structural distinctions is crucial for designing controlled in vitro experiments and optimizing reagent selection within the PX1 research portal.

Quality Assurance Standards: RP-HPLC, Mass Spectrometry, and Endotoxin Limits

To guarantee that the VIP peptide price reflects superior molecular purity and chemical stability, PX1 Research subjects every production lot to rigorous analytical characterization. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) provides quantitative data on peptide purity, confirming that all non-target UV-absorbing species are identified and minimized.

Electrospray Ionization Mass Spectrometry (ESI-MS) further confirms that the synthesized 28-amino acid sequence contains no missing residues, incorrect protecting group cleavage artifacts, or methionine oxidation. Detailed testing methodology and analytical parameters are further outlined in our guide on peptide purity testing via HPLC and MS. Furthermore, strict endotoxin testing ensures that cell culture assays evaluating cytokine secretion or vascular reactivity remain unconfounded by bacterial lipopolysaccharide (LPS) artifacts.

Reconstitution Protocols and Reagent Handling in Laboratory Environments

Lyophilized VIP peptide should be reconstituted under sterile laminar flow conditions using appropriate laboratory solvents. Because VIP contains hydrophobic residues as well as basic amino acids, solubilization procedures must be selected based on the planned downstream application.

For general in vitro binding assays, lyophilized VIP is typically dissolved in sterile, bacteriostatic water or sterile dilute acetic acid (0.1% v/v) to prepare a concentrated stock solution. Once initial solubilization is achieved, the solution may be diluted into physiological buffers such as Phosphate-Buffered Saline (PBS) or cell culture media containing 0.1% Bovine Serum Albumin (BSA) to prevent non-specific adsorption to plastic vessel walls. Automated liquid handlers and research personnel should utilize low-binding polypropylene microcentrifuge tubes during all reconstitution steps.

Storage Conditions and Stability Metrics for Lyophilized VIP

Proper storage protocol is vital to maintain the structural integrity of VIP and preserve its binding kinetics over extended experimental timelines. Lyophilized VIP peptide should be stored desiccated at -20°C or -80°C upon receipt, away from direct light exposure.

Under these conditions, lyophilized VIP remains stable for up to 24 months without significant degradation. Upon reconstitution into aqueous liquid stock, the peptide solution should be divided into single-use laboratory aliquots to avoid repeated freeze-thaw cycles, which promote peptide aggregation and methionine oxidation. Reconstituted aliquots stored at -80°C maintain analytical stability for up to 3 to 6 months. For extensive technical specs, research investigators can consult the PX1 wholesale supply framework.

Institutional Sourcing, Procurement, and Batch Traceability

Procuring high-grade research reagents requires clear documentation, reproducible manufacturing, and reliable logistics. Academic institutions, biotechnology firms, and contract research organizations (CROs) require transparent lot tracking to validate experimental continuity across multi-phase study designs.

PX1 Research maintains comprehensive analytical records for every batch, issuing a third-party verified Certificate of Analysis detailing exact purity percentages, mass spec profiles, and endotoxin levels. Facilities sourcing larger quantities for screening panels or extended preclinical series can utilize our institutional portal to review batch documentation and manage wholesale lab accounts.